PatientsLikeMe ™

all
Skip over navigation
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Filter page content by community
All Communities

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Zantac
See also: Ranitidine Prescription

What is Ranitidine HCL? Over-the-counter ranitidine is an H2 blocker. It is used to prevent and treat symptoms of heartburn associated with acid indigestion and sour stomach. It decreases the amount of acid made in the stomach. Ranitidine is also available in prescription strength dosing. Read more...Click to read more below


Reasons Taken

47 patients in the community are taking or have taken Ranitidine HCL.

Reason # Patients Percentage of patients
Other 26 55%
General health 7 14%
Acid reflux (Gastroesophageal reflux disease GERD) 6 12%
Heart burn 1 2%
Heartburn 1 2%
Stomach pain 1 2%

Dosages

Based on the patients currently taking Ranitidine HCL.

Top 10 (Show all)

All (Show Top 10)

  0 mg none 0 other none 2 mg day 3 other day 4 tps. day 25 mg day 30 mg day 37.5 mg day 40 mg day 75 mg day 150 mg day 225 mg day 300 mg day 300 day 600 mg day
  3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 14 Number of Patients: 14 1 Number of Patients: 1 5 Number of Patients: 5 1 Number of Patients: 1 4 Number of Patients: 4  

Duration

How long current patients have been taking Ranitidine HCL or how long patients were taking Ranitidine HCL before stopping.

Currently taking Ranitidine HCL

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
3
2
0
4
19

Stopped taking Ranitidine HCL

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
2
1
0
1
Why Patients Stopped Taking Ranitidine HCL (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 3 60% Course of treatment ended: 60%
Not indicated 2 40% Not indicated: 40%
Other 1 20% Other: 20%


Back to top